Location: Home
  • search
  • go
  • Relate News
  • 7/14/2021PharmaDJ's China Licensing Deals Tracker: May 2021
  • 7/14/2021NMPA Announces OTC Switch of Four Rx Drug Products
  • 7/14/2021Innovent and Ascentage Reach Strategic Deal for Olverembatinib in Chin...
  • 7/14/2021Teva's NDA for Copaxone Injection Accepted by the Chinese CDE
  • 7/14/2021AstraZeneca Granted Chinese Approval for New SCLC Indication of Imfinz...
  • 7/13/2021New Report: Global and Chinese CDMO Markets to Rise 11.2% and 19.9% CA...
  • 7/13/2021Biogen Licenses Certain Rights of Anticancer Orelabrutinib from InnoCa...
  • 7/13/2021Kintor Pharma Greenlighted for Pyrilutamide's Phase II Trial in the US
  • 7/13/2021Everest Medicines and Tencent Enters Strategic Commercial Partnership
  • 7/13/2021Takeda's NSCLC Drug Mobocertinib NDA Accepted with Priority Review in ...
  • 7/13/2021CDE Seeks Comments on Draft ICH Guidelines S12
  • 7/13/2021PharmaDJ's China Market Approval Tracker: May 2021
  • 7/13/2021Patent Linkage System in China: Judicial Provisions and Administrative...
  • 7/13/2021Nikkei: Avigan Maker Fujifilm Faces Patent Risk from China's AMMS
  • 7/13/2021Seizing Opportunities in China's Healthcare Sector
  • 7/12/2021Eli Lilly and Tencent Enter Digital MedPharm Partnership in China
  • 7/12/2021Gilead Sciencesand JD Health Enter Strategic Partnership for Digital H...
  • 7/11/2021Shanghai I-Mab  Enters Two New Oncology Partnerships
  • 7/11/2021Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs Approved for Phase ...
  • 7/9/2021MOFCOM Plans to Beef Up Scrutinization of Foreign Investment
  • 7/9/2021Takeda's NDA for Mobocertinib (TAK-788) Accepted in China as a Treatme...
  • 7/9/2021Recent Executive Moves
  • 7/9/2021Innovent's NDA for FGFR1/2/3 Inhibitor (Pemigatinib) Accepted in China...
  • 7/9/2021Schott Inaugurates New Glass Tubing Plant in China
  • 7/8/2021Parexel Expands A/P Capability with New China Depot Planned
  • 7/8/2021CDE Solicits Comments on the Technical Guidelines for Clinical Pharmac...
  • 7/8/2021CDE Solicits Comments on the Technical Guidelines for Pharmacokinetic ...
  • 7/8/2021CDE Solicits Comments on the Guidelines for Clinical Research of Late ...
  • 7/8/2021CDE Solicits Comments on the Technical Guidelines for Writing Safety R...
  • 7/8/2021Sparx Therapeutics to Build Its First ADC Production Facility in Yangz...
  • Page:203/799 Total number of articles:23944: [First][<<] [201] [202] [203] [204] [205] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group